In this article (Cancer Prev Res 2011;4;354–64), which was published in the March 2011 issue of Cancer Prevention Research (1), there was an erroneous entry for 2 data-points at the 4 g dose due to author error. Figure 2 in the article had 1 endpoint errantly deleted from the figure but not from statistical calculations. The means in Fig. 2 change slightly at the 4 g dose. The P value remains unchanged and the Aberrant Crypt Foci (ACF) change at the 2 g dose remains insignificant while still significant at the 4 g dose (P < 0.005). The corrected figure appears below.
Skip Nav Destination
Correction| December 04 2012
Correction: Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Online Issn: 1940-6215
Print Issn: 1940-6207
©2012 American Association for Cancer Research.
Cancer Prev Res (Phila) (2012) 5 (12): 1407.
- Views Icon Views
- Share Icon Share
- Search Site
Article Versions Icon
- Version of Record December 4 2012
Correction: Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia. Cancer Prev Res (Phila) 1 December 2012; 5 (12): 1407. https://doi.org/10.1158/1940-6207.CAPR-12-0356
Download citation file:
Citing articles via